News & Updates

Treatment with memantine significantly reduces hair pulling and skin-picking symptoms when compared with placebo, demonstrating relatively high efficacy and tolerability, reports a study.

A deep learning–based artificial intelligence (AI) model developed by researchers from the Chinese University of Hong Kong exhibits good accuracy in detection of intracranial haemorrhage (ICH) on CT scans.

Treatment with remdesivir reduced mortality in a large cohort of hospitalized patients requiring high-flow oxygen, according to a study presented at ECCMID 2023.

Individuals with germline genetic alterations, particularly the BRCA1/2 pathogenic/likely pathogenic variant (PV/LPV), do not appear to experience any significant increase in post-COVID vaccination side effects, as reported in a study from Singapore.

In the management of advanced cancers, physicians and their patients may prefer treatment with nivolumab 3 mg/kg biweekly, nivolumab 240 mg weekly, or nivolumab 3 mg/kg plus ipilimumab 1 mg/kg triweekly due to their relatively low risk of treatment-related adverse events (TRAEs), treatment discontinuation due to TRAEs (TDAE), and serious adverse events (SAEs), suggests a study.